Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Gw Pharmaceuticals (GWP)

GW Pharm.
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GWP
DateTimeSourceHeadlineSymbolCompany
27/06/201610:00UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
23/06/201607:30UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
22/06/201614:22UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
21/06/201612:09Alliance NewsAlliance NewsGW Pharmaceuticals Targets Infantile Spasms For Epidiolex DevelopmentLSE:GWPGW Pharm.
21/06/201612:00UK RegulatoryGW Pharmaceuticals PLC Epidiolex Development Program in Infantile SpasmsLSE:GWPGW Pharm.
17/06/201617:05UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
08/06/201616:54UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
31/05/201613:25UK RegulatoryGW Pharmaceuticals PLC Total Voting RightsLSE:GWPGW Pharm.
31/05/201612:00UK RegulatoryGW Pharmaceuticals PLC Presents at Goldman Sachs and Jefferies ConferenceLSE:GWPGW Pharm.
16/05/201612:00UK RegulatoryGW Pharmaceuticals PLC GWP presenting at UBS Global Healthcare ConferenceLSE:GWPGW Pharm.
13/05/201615:50UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
11/05/201617:40Alliance NewsAlliance NewsDIRECTOR DEALINGS: GW Pharmaceuticals Non-Executive Sells SharesLSE:GWPGW Pharm.
11/05/201617:19UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
05/05/201612:25Alliance NewsAlliance NewsGW Pharmaceuticals First Half Loss Widens, Epidolex Progress ContinuesLSE:GWPGW Pharm.
05/05/201612:00UK RegulatoryGW Pharmaceuticals PLC Half-year ReportLSE:GWPGW Pharm.
04/05/201612:00UK RegulatoryGW Pharmaceuticals PLC Presenting at BoAML 2016 Healthcare ConferenceLSE:GWPGW Pharm.
29/04/201613:37UK RegulatoryGW Pharmaceuticals PLC Total Voting RightsLSE:GWPGW Pharm.
28/04/201612:00UK RegulatoryGW Pharmaceuticals PLC Notice of ResultsLSE:GWPGW Pharm.
21/04/201612:11Alliance NewsAlliance NewsGW Pharmaceuticals Gets Orphan Drug Designation For Tuberous SclerosisLSE:GWPGW Pharm.
21/04/201612:00UK RegulatoryGW Pharmaceuticals PLC Orphan Drug Designation for Cannabidiol in TSCLSE:GWPGW Pharm.
11/04/201612:18Alliance NewsAlliance NewsGW Pharma Starts Phase III Epidiolex Trials In Third IndicationLSE:GWPGW Pharm.
11/04/201612:00UK RegulatoryGW Pharmaceuticals PLC Initiates Ph 3 Study in Tuberous Sclerosis ComplexLSE:GWPGW Pharm.
01/04/201615:24UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
23/03/201617:07UK RegulatoryGW Pharmaceuticals PLC Result of AGMLSE:GWPGW Pharm.
18/03/201615:35UK RegulatoryGW Pharmaceuticals PLC Block Listing ApplicationLSE:GWPGW Pharm.
15/03/201612:32Alliance NewsAlliance NewsTAKING AIM: Numis Tips Hat To GW Pharmaceuticals' Trial ResultsLSE:GWPGW Pharm.
14/03/201613:20Dow Jones NewsGW Pharmaceuticals Gets Positive Result for Cannabis-based Epilepsy DrugLSE:GWPGW Pharm.
14/03/201611:44Alliance NewsAlliance NewsUPDATE: GW Pharmaceuticals Shares Double On Epidiolex Trial ResultsLSE:GWPGW Pharm.
14/03/201611:09Alliance NewsAlliance NewsGW Pharmaceuticals Sees Positive Phase III Epidiolex Study ResultsLSE:GWPGW Pharm.
14/03/201611:00UK RegulatoryGW Pharmaceuticals PLC Epidiolex Positive Phase 3 Pivotal Study ResultsLSE:GWPGW Pharm.
 Showing the most relevant articles for your search:LSE:GWP